Your reference journal for coronary, valvular and structural interventions

issue

Sep 22, 2015

Volume 11 Number 5

Editorial

The era of a new generation of interventionalists: a hybrid of a surgeon and an interventionalist?

Serruys PW

10.4244/EIJV11I5A98

free

Time, space and leaps of faith

Dauerman H

10.4244/EIJV11I5A99

free

Further refining the technique: new concepts in TAVI research

Aldalati O, MacCarthy P

10.4244/EIJV11I5A100

free

EAPCI community news

EAPCI Focus on the EAPCI Board Elections 2016

free

Coronary interventions

Optimal catchment area and primary PCI centre volume revisited: a single-centre experience in transition from high-volume centre to “mega centre” for patients with ST-segment elevation myocardial infarction

Schoos M, Pedersen F, Holmvang L, Engstrøm T, Saunamäki K, Helqvist S, Kastrup J, Mehran R, Dangas G, Jørgensen E, Kelbæk H, Clemmensen P

10.4244/EIJY14M11_07

free

Inter-hospital transfer for primary angioplasty: delays are often due to diagnostic uncertainty rather than systems failure and universal time metrics may not be appropriate

Tarkin J, Malhotra A, Apps A, Smith R, Di Mario C, Rogers P, Lane R, Kabir T, Mason M, Ilsley C, Whitbread M, Dalby M

10.4244/EIJV11I5A103

free

Myocardial perfusion grade predicts final infarct size and left ventricular function in patients with ST-elevation myocardial infarction treated with a pharmaco-invasive strategy (thrombolysis and early angioplasty)

Bethke A, Halvorsen S, Bohmer E, Abdelnoor M, Arnesen H, Hoffmann P

10.4244/EIJY15M04_02

free

A comparison of multivessel and culprit vessel percutaneous coronary intervention in non-ST-segment elevation acute coronary syndrome patients with multivessel disease: a meta-analysis

Qiao Y, Li W, Mohamed S, Nie S, Du X, Zhang Y, Jia C, Wang X, Liu X, Ma C

10.4244/EIJV11I5A104

free

Differences in coronary risk factors, procedural characteristics, mortality and stent thrombosis between two all-comers percutaneous coronary intervention registries from Europe and Japan: a patient-level data analysis of the Bern-Rotterdam and j-Cypher registries

Onuma Y, Kimura T, Räber L, Magro M, Girasis C, van Domburg R, Windecker S, Mitsudo K, Serruys PW

10.4244/EIJY14M06_09

free

A first-in-man clinical evaluation of Ultimaster, a new drug-eluting coronary stent system: CENTURY study

Barbato E, Salinger-Martinovic S, Sagic D, Beleslin B, Vrolix M, Neskovic A, Jagic N, Verheye S, Mehmedbegovic Z, Wijns W

10.4244/EIJY14M08_06

free

Five-year clinical outcome of the Nobori drug-eluting coronary stent system in the treatment of patients with coronary artery disease: final results of the NOBORI 1 trial

Chevalier B, Wijns W, Silber S, Garcia E, Serra A, Paunovic D, Serruys PW

10.4244/EIJY14M12_13

free

Bioresorbable everolimus-eluting vascular scaffold for the treatment of chronic total occlusions: CTO-ABSORB pilot study

Vaquerizo B, Barros A, Pujadas S, Bajo E, Estrada D, Miranda-Guardiola F, Rigla J, Jiménez M, Cinca J, Serra A

10.4244/EIJY14M12_07

free

Comparison of neointimal coverage between everolimus-eluting stents and sirolimus-eluting stents: an optical coherence tomography substudy of the RESET (Randomized Evaluation of Sirolimus-eluting versus Everolimus-eluting stent Trial)

Kubo T, Akasaka T, Kozuma K, Kimura K, Kawamura M, Sumiyoshi T, Ino Y, Morino Y, Tanabe K, Kadota K, Kimura T

10.4244/EIJV11I5A109

free

Impact of the orbital atherectomy system on a coronary calcified lesion: quantitative analysis by light attenuation in optical coherence tomography

Sotomi Y, Shlofmitz RA, Nakatani S, Onuma Y, Serruys PW

10.4244/EIJV11I5A110

free

Reversal of flow between serial bifurcation lesions: insights from computational fluid dynamic analysis in a population-based phantom model

Barlis P, Poon E, Thondapu V, Grundeken M.J, Tu S, Hayat U, Ooi A, Moore S, Tenekecioglu E, Wykrzykowska JJ, Serruys PW

10.4244/EIJV11I5A111

free

Interventions for structural heart disease

Clinical impact of coronary protection during transcatheter aortic valve implantation: first reported series of patients

Abramowitz Y, Chakravarty T, Jilaihawi H, Kashif M, Kazuno Y, Takahashi N, Maeno Y, Nakamura M, Cheng W, Makkar R

10.4244/EIJV11I5A112

free

The Leaflex™ Catheter System – a viable treatment option alongside valve replacement? Preclinical feasibility of a novel device designed for fracturing aortic valve calcification

Jonas M, Rozenman Y, Moshkovitz Y, Hamdan A, Kislev Y, Tirosh N, Sax S, Trumer D, Golan E, Raanani E

10.4244/EIJY14M11_10

free

Proof of concept of FOLDAVALVE, a novel 14 Fr totally repositionable and retrievable transcatheter aortic valve

Kheradvar A, Groves E, Tseng E

10.4244/EIJY15M03_04

free

Unintentional sealing of the mitral valve with a second MitraClip. “Once bitten, twice shy”

Alipour A, Swaans MJ, Post M, Rensing BJ, Eefting F, Van Der Heyden JA

10.4244/EIJV11I5A115

free

CoreValve Evolut R implantation as valve-in-valve in an Edwards SAPIEN 3 to treat paravalvular regurgitation

Bruschi G, Soriano F, Musca F, Nava S, Einaudi A, Garascia A, Belli O, Barosi A, Fratto P, Colombo P, Russo C, Gagliardone M, Klugmann S

10.4244/EIJV11I5A116

free

Treatment of pure aortic insufficiency after aortic stentless valve implantation: increasing safety with a transcatheter inflatable fully repositionable valve

Kische S, D’Ancona G, Ortak J, Ince H

10.4244/EIJV11I5A117

free

Early hypoattenuated leaflet thickening and restricted leaflet motion of a Lotus transcatheter heart valve detected by 4D computed tomography angiography

Schoechlin S, Ruile P, Neumann F, Pache G

10.4244/EIJV11I5A118

free

Interventions for hypertension and heart failure

Sympathetic denervation of heart and kidney induces similar effects on ventricular electrophysiological properties

Huang B, Yu L, He B, Wang S, Lu Z, Liao K, Wang Z, Zhou X, He W, Jiang H

10.4244/EIJV11I5A119

free

How should i treat?

How should I treat a significant and inoperable left main coronary atherosclerotic disease (LMCAD) in the setting of a severely depressed left ventricular systolic function and severe aorto-iliac atherosclerotic disease?

Ibrahim A, Preeyanont P, Rab S

10.4244/EIJV11I5A120

free